Recent research highlights the ongoing debate regarding the environmental impact of NSAIDs in wastewater and their potential toxicity to aquatic life. A comprehensive critical review led by Näslund J and colleagues suggests that there is currently no clear documentation linking non-steroidal anti-inflammatory drugs (NSAIDs) to histopathological effects in fish exposed specifically to treated municipal effluents. While laboratory studies have shown that high concentrations of these drugs can damage the kidney and liver of fish, the actual levels found in treated water are often significantly lower than those required to cause harm.

The review scrutinized various reported findings, such as hepatocellular necrosis and nephron clusters. Consequently, the researchers found that the lowest observed effect concentrations (LOECs) for liver damage were far higher than the concentrations typically encountered downstream from treatment plants. Furthermore, the reliability of studies reporting effects at lower concentrations was called into question due to inconsistent experimental designs and reporting standards across the field.

Monitoring NSAIDs in Wastewater for Environmental Safety

This study underscores the need for more standardized research methodologies in the future. Because study designs, species choice, and exposure regimes vary so widely, comparing results across different regions becomes exceptionally difficult. For medical professionals and pharmacologists, this highlights the complexity of ecopharmacovigilance. Therefore, future research must adopt comparable designs to determine the true environmental risk posed by pharmaceutical residues in our water systems.

In the context of public health, understanding how these medications behave after they leave the patient is vital. Although the current review provides some reassurance regarding treated effluents, the high consumption of NSAIDs in countries like India means that monitoring remains a priority. Therefore, clinicians and pharmacists should remain aware of the broader ecological footprint of common prescriptions to support sustainable healthcare practices.

Frequently Asked Questions

Can NSAIDs in wastewater cause kidney damage in fish?

While laboratory studies using high concentrations have shown kidney and liver damage in fish, current evidence suggests that the levels found in treated municipal wastewater are generally too low to cause these specific histopathological changes.

Why are study results on fish pathology so inconsistent?

Variations in fish species, exposure times, and the methodologies used to analyze tissue samples make it difficult to detect overlapping effects or reach firm conclusions about the toxicity of pharmaceutical residues.

Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Näslund J et al. No Clear Evidence of Histopathological Effects Linked to NSAIDs in the Kidney or Liver of Fish Exposed to Treated Municipal Wastewaters. Toxicol Pathol. 2026 Apr 05. doi: 10.1177/01926233261423895. PMID: 41936100.


2. Silva JF et al. Non-steroidal anti-inflammatory drugs and oxidative stress biomarkers in fish: a meta-analytic review. Toxicol Rep. 2025.


3. Schwaiger J et al. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol. 2004;68(2):141-50.